Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2019 call → NOWe need to determine if management conveys that successive engagements of the same kind are coming in at progressively larger size. Look for explicit statements about deal size, order size, contract size, etc., compared to past. The transcript mentions various orders, but does management say that the size of individual orders is increasing? For example, they mention a $9.8 million delivery order, a $24.4 million order for manpack terminals, etc. But do they compare to past sizes? They talk about growth in sales, but not necessarily that each new order is larger than previous ones. They mention "we are optimistic that we are experiencing a period of multi-year revenue growth for our satellite earth station product line." That's about revenue growth, not unit size. They mention "we continue to see the market with our Heights products" and "double-digit sales growth this year." That's volume. They mention "we have responded and are responding to several proposals with large wireless carriers, some of them sole source opportunities" - that's pipeline, not signed. They mention "we are still waiting for feedback from the U.S. government in response to a large multi-year RFP" - that's future. They mention "we expect the U.S. government to continue to test such units and thereafter place additional orders for our MT-2025 transceivers sometime in fiscal 2019" - that's future. No explicit statement that the size of individual orders is escalating. They talk about "we are experiencing positive business momentum" but not about unit size. The question asks: does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago? I don't see that. They mention a $9.8 million order, but no comparison to past orders of same type. They mention "we received over $24.4 million of orders to supply man pack satellite terminals" - but is that larger than before? Not stated. They mention "we also receive $7.1 million order" etc. No comparison. They mention "we believe our BFT HC Transceivers can fill a vital need" but no size escalation. So answer NO. Also note: they mention "we are increasing our revenue goal" but that's overall revenue, not unit size. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.